Advances in Hematological Malignancies
Recent centuries have witnessed remarkable progress in the domain of hematological malignancies. Novel approaches such as targeted drugs, immunotherapies, and manipulation are revolutionizing the survival rates for patients with blood cancers. Clinical trials continue to explore these innovative techniques, offering potential for more successful tr